Pliant Therapeutics (PLRX) Earnings Date, Estimates & Call Transcripts $0.86 +0.01 (+0.86%) Closing price 10/27/2026 04:00 PM EasternExtended Trading$0.86 0.00 (-0.01%) As of 10/27/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings Pliant Therapeutics Earnings Summary Pliant Therapeutics issued Q2 2026 earnings on August 11, 2026, reporting an EPS of -$0.36, which missed the consensus estimate of -$0.34 by $0.02. With a trailing EPS of -$1.49, Pliant Therapeutics' earnings are expected to decrease next year, from ($1.42) to ($1.53) per share. Upcoming Q3 Earnings DateNov. 5After Market ClosesEstimatedConsensus EPS (Aug. 11) -$0.34 Actual EPS (Aug. 11) -$0.36 Missed By -$0.02 Q2 2026 Earnings ResourcesQ2 2026 Earnings Report Press Release (8-K) Quarterly Report (10-Q)PLRX Upcoming EarningsPliant Therapeutics' Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedules, with a conference call scheduled on Friday, November 6, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Pliant Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pliant Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataPLRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Pliant Therapeutics Upcoming Earnings ConsensusReport DateNovember 5, 2026Consensus EPS Estimate-$0.37Pliant Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.42) EPSNext Year EPS Consensus Estimate ($1.53) EPS Pliant Therapeutics Earnings History by Quarter 10/28/2024 - 10/28/2026 Report Date Report Date From Report Date To 3M6MYTD1Y2Y3Y5Y10Y More filters Fewer filters Done 0 Results Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/5/2026(Estimated)--$0.37------8/11/2026Q2 2026-$0.3418-$0.36 -$0.0182-$0.36--5/11/2026Q1 2026-$0.36-$0.32+$0.04-$0.32--3/11/2026Q4 2025-$0.44-$0.35+$0.09-$0.38--11/6/2025Q3 2025-$0.53-$0.43+$0.10-$0.43$3.33M-8/7/2025Q2 2025-$0.62-$0.71 -$0.09-$0.71--3/3/2025Q4 2024-$0.99-$0.82+$0.17-$0.82$0.08M-11/7/2024--$0.99-$0.95+$0.04-$0.95-- Pliant Therapeutics Earnings - Frequently Asked Questions When is Pliant Therapeutics' earnings date? Pliant Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 5th, 2026 based off last year's report dates. Learn more on PLRX's earnings history. Did Pliant Therapeutics beat their earnings estimates last quarter? In the previous quarter, Pliant Therapeutics (NASDAQ:PLRX) missed the analysts' consensus estimate of ($0.34) by $0.02 with a reported earnings per share (EPS) of ($0.36). Learn more on analysts' earnings estimate vs. PLRX's actual earnings. What is Pliant Therapeutics' EPS forecast for next year? Pliant Therapeutics' earnings are expected to decrease from ($1.42) per share to ($1.53) per share in the next year. More Earnings Resources from MarketBeat Related Companies Alector Earnings Date MacroGenics Earnings Date CAMP4 Therapeutics Earnings Date Evommune Earnings Date PepGen Earnings Date Entrada Therapeutics Earnings Date Compugen Earnings Date Cartesian Therapeutics Earnings Date Sionna Therapeutics Earnings Date ADC Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple's Foldable iPhone Sold Out in Minutes, But Wall Street Has QuestionsCoca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest StrengthWhirlpool's Stock Collapse Raises a Bigger Question About Its Recovery PotentialAnalysts Turn Bullish on Meta Platforms Despite Post-Earnings FallLockheed Martin's F-35 Deal Could Change How Wall Street Values the StockIntel's $155 Price Target Raises a Bigger Question About Its Turnaround PotentialMerck and Moderna's Cancer Vaccine Worked—Who Gets Paid? Earnings data for NASDAQ:PLRX is sourced from Fiscal.ai, with the most recent quarter reported on 8/11/2026. New results are added as companies report their earnings. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredYesterday's deadline changed everythingIn June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times th...Behind the Markets | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pliant Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pliant Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
